Preclinical safety, pharmacokinetics, pharmacodynamics, and biodistribution studies with Ad35K++ protein: a novel rituximab cotherapeutic.
about
Preclinical safety, pharmacokinetics, pharmacodynamics, and biodistribution studies with Ad35K++ protein: a novel rituximab cotherapeutic.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Preclinical safety, pharmacoki ...... novel rituximab cotherapeutic.
@ast
Preclinical safety, pharmacoki ...... novel rituximab cotherapeutic.
@en
type
label
Preclinical safety, pharmacoki ...... novel rituximab cotherapeutic.
@ast
Preclinical safety, pharmacoki ...... novel rituximab cotherapeutic.
@en
prefLabel
Preclinical safety, pharmacoki ...... novel rituximab cotherapeutic.
@ast
Preclinical safety, pharmacoki ...... novel rituximab cotherapeutic.
@en
P2093
P2860
P50
P356
P1476
Preclinical safety, pharmacoki ...... novel rituximab cotherapeutic.
@en
P2093
Ajay Gopal
André Lieber
Audrey Baldessari
Chung-Huei Katherine Wang
Haishan Jang
Hongjie Wang
Kamola Saydaminova
Maximilian Richter
Michael Gough
P2860
P356
10.1038/MTM.2016.13
P577
2016-03-30T00:00:00Z